Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...

AI-ECG: A New Market For A Century-Old Test

The 12-lead ECG hasn't changed in a century. The algorithms reading it have. Three CEOs and one educator on whether doctors ...
Healio

Fully automated ECG analysis system gains FDA 510(k) clearance

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Automated ECG interpretation system gains FDA clearance ...
UC San Francisco

Using AI in Electrocardiogram Analysis Can Improve Diagnosis and Treatment of Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden death in adolescents and initial detection is often difficult. A new UC San Francisco study finds that Artificial Intelligence-enhanced ...

AccurKardia Granted Patent for AI-Driven ECG Detection of Cardiac Amyloidosis

AccurKardia, Inc., an ECG analytics software company focused on establishing ECG as a broad biomarker, today announced that ...

Thinking about buying a smartwatch for health tracking? Don't overlook ECG feature

ECG-enabled smartwatches can help monitor heart rhythm patterns, flag irregularities and add useful context to everyday ...